STRS Ohio
- SEC CIK
- 0000820478
- Latest filing
- Jul 30, 2026
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by STRS Ohio, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q2 2026 holdings
- Shares (Q2 2026)
- 17,300
- Value
- $1.09M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 17,300 | $1.09M | <0.1% | +8,500+96.6% | Added | Holders |
| Q1 2026 | 8,800 | $617.3K | <0.1% | +400+4.8% | Added | Holders |
| Q4 2025 | 8,400 | $687.8K | <0.1% | −2,100−20.0% | Reduced | Holders |
| Q3 2025 | 10,500 | $624.0K | <0.1% | −8,000−43.2% | Reduced | Holders |
| Q2 2025 | 18,500 | $749.4K | <0.1% | +12,900+230.4% | Added | Holders |
| Q1 2025 | 5,600 | $287.7K | <0.1% | +400+7.7% | Added | Holders |
| Q4 2024 | 5,200 | $287.9K | <0.1% | +5,200 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −3,800−100.0% | Sold out | Holders |
| Q1 2023 | 3,800 | $47.0K | <0.1% | −19,300−83.5% | Reduced | Holders |
| Q4 2022 | 23,100 | $338.0K | <0.1% | −4,900−17.5% | Reduced | Holders |
| Q3 2022 | 28,000 | $479.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 28,000 | $408.0K | <0.1% | +25,900+1,233.3% | Added | Holders |
| Q1 2022 | 2,100 | $35.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,100 | $47.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,100 | $45.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,100 | $60.0K | <0.1% | +600+40.0% | Added | Holders |
| Q1 2021 | 1,500 | $48.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.